The biotechnology company could seek approval for its coronavirus vaccine by the end of the year, according to the Wall Street Journal. Carnival Corp., ...
News
- Gilead Sciences, Matson rise; WD-40, Eli Lilly fall
- Initial public offerings scheduled to debut next week
Proposed Nasdaq symbol GLSI. Business: Phase 3 biotech developing immunotherapies for breast cancer. nCino - Wilmington , N.C., 7.6 million shares, ...
- US bets on small, untested company to deliver COVID vaccine
BARDA is the Biomedical Advanced Research and Development Authority within HHS. Suddenly ApiJect's 5-year plan to mass produce its devices ...
- Bob Goeltz bolts Unity Biotechnology to become CFO at Arcus Biosciences; John Johnson tapped ...
→ San Antonio-based bioAffinity Technologies has named Alexion co-founder Stephen Squinto vice chairman of their board of directors, and the cancer ...
- AP Explains: Why India cases are rising to multiple peaks
... of clinical trial, including one by Bharat Biotech that the Indian Council on Medical Research pledged would have results from human trials by Aug.